These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevalence of vitamin D deficiency in HIV-positive, antiretroviral treatment-naïve patients in a single centre study. Gedela K, Edwards SG, Benn P, Grant AD. Int J STD AIDS; 2014 Jun; 25(7):488-92. PubMed ID: 24352123 [Abstract] [Full Text] [Related]
6. Risk factors associated with hypovitaminosis D in HIV/aids-infected adults. Canuto JM, Canuto VM, de Lima MH, de Omena AL, Morais TM, Paiva AM, Diniz ET, de Almeida DJ, Ferreira SM. Arch Endocrinol Metab; 2015 Feb; 59(1):34-41. PubMed ID: 25926112 [Abstract] [Full Text] [Related]
9. Vitamin D Insufficiency/Deficiency in HIV-Infected Inner City Youth. Poowuttikul P, Thomas R, Hart B, Secord E. J Int Assoc Provid AIDS Care; 2014 Feb; 13(5):438-42. PubMed ID: 23881908 [Abstract] [Full Text] [Related]
10. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. Miller CD, El-Kholi R, Faragon JJ, Lodise TP. Pharmacotherapy; 2007 Oct; 27(10):1379-86. PubMed ID: 17896893 [Abstract] [Full Text] [Related]
14. Vitamin D deficiency in patients admitted to the general ward with breast, lung, and colorectal cancer in Buenos Aires, Argentina. Aguirre M, Manzano N, Salas Y, Angel M, Díaz-Couselo FA, Zylberman M. Arch Osteoporos; 2016 Oct; 11():4. PubMed ID: 26732091 [Abstract] [Full Text] [Related]
15. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009. Blair JM, Fagan JL, Frazier EL, Do A, Bradley H, Valverde EE, McNaghten A, Beer L, Zhang S, Huang P, Mattson CL, Freedman MS, Johnson CH, Sanders CC, Spruit-McGoff KE, Heffelfinger JD, Skarbinski J, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC. MMWR Suppl; 2014 Jun 20; 63(5):1-22. PubMed ID: 24941443 [Abstract] [Full Text] [Related]
17. [Prevalence of potential drug-drug interactions involving antiretroviral drugs in Buenos Aires, Argentina]. Córdova E, Porteiro N, Loiza E, Mingrone H. Rev Chilena Infectol; 2016 Oct 20; 33(Suppl 1):54-59. PubMed ID: 28453027 [Abstract] [Full Text] [Related]
19. Clinical outcomes of first-line antiretroviral therapy in Latin America: analysis from the LATINA retrospective cohort study. Angriman F, Belloso WH, Sierra-Madero J, Sánchez J, Moreira RI, Kovalevski LO, Orellana LC, Cardoso SW, Crabtree-Ramirez B, La Rosa A, Losso MH. Int J STD AIDS; 2016 Feb 20; 27(2):118-26. PubMed ID: 25740759 [Abstract] [Full Text] [Related]
20. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London. Eyeson JD, Tenant-Flowers M, Cooper DJ, Johnson NW, Warnakulasuriya KA. J Oral Pathol Med; 2002 Mar 20; 31(3):169-74. PubMed ID: 11903824 [Abstract] [Full Text] [Related] Page: [Next] [New Search]